Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131565) titled 'A clinical study evaluating the efficacy and safety of early treatment conversion of aflibercept 8mg in patients with neovascular age-related macular degeneration (nAMD)' on Sept. 4.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Eye & ENT hospital of Fudan University
Condition:
Age-related macular degeneration
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-04
Target Sample Size: Experimental group:45;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=321133
Published by HT Digital Content ...